Clinical Trials in Pittsburgh

Showing 19161-19180 of 21,047 trials

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

NCT00486538

This study is designed to determine the clinical efficacy and toxicity of ABT 869 in the treatment of subjects with advanced renal cell carcinoma who have previously received treatment with sunitinib.

Advanced Renal Cell Carcinoma

AbbVie (prior sponsor, Abbott)53 participantsStarted Jun 2007

Sacramento, California, United States • Washington D.C., District of Columbia, United States • Chicago, Illinois, United States +10 more locations

COMPLETEDPhase 3< 1 mile

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

NCT00083954

The purpose of this study is to determine the efficacy of quetiapine compared to placebo in the treatment for a major depressive episode in patients with bipolar disorder after receiving treatment for up to 8 weeks.

Bipolar Disorder

AstraZeneca530 participantsStarted Jun 2004

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Cerritos, California, United States +33 more locations

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

Find Trials by Condition in Pittsburgh

Iressa Expanded Access Program (EAP)

Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania

A Study in Erectile Dysfunction

Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

S9912 Combination Chemo in Stage III Ovarian Cancer,

Study of Acid Reflux in Asthma

A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer

Study of Antidepressants in Parkinson's Disease

Seroquel in Bipolar Depression Versus SSRI

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)

An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome

A Study Of CP-690,550 In Stable Kidney Transplant Patients

An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders